See this link for another piece highlighting how i
Post# of 82672
https://spectator.org/on-patents-trump-bucks-...nopolists/
Fortunately, this appears to be changing in at least one area: namely, the administration’s policy on patents. This can be seen most clearly in the Trump Justice Department’s brief in the Supreme Court case of Oil States Energy Services v. Greene’s Energy Group, LLC.
Why is this brief such a thumb in the eye of not just pharma, but monopolists and patent trolls everywhere? Because it defends the inter partes review (IPR) process, one of the few effective means by which bad patents can be shut down. IPRs enable those accused of infringing invalid patents to take their case straight to a court convened by the U.S. Patent and Trademark Office (USPTO), known as the Patent Trial and Appeal Board (PTAB), rather than being forced to fight their cases through the laborious court system, giving both trial lawyers and patent trolls a windfall. No surprise, then, that the defenders of the trolls are crying foul over the Trump administration’s choice to defend the process, as well as to continue implementing it under incoming USPTO director Andrei Iancu.